⚕ GalenOps CRO console
← 701 (USA)

701-1115

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2012-11-30
Adverse events
9
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

moderate assessed 2026-08-18

Moderate APPLICATION SITE DERMATITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 51.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-02 (study day 3.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-02 (study day 3.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-26 (study day 27.0); relationship: POSSIBLE

mild assessed 2026-08-18

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2012-12-26 (study day 27.0); relationship: POSSIBLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-19 (study day 51.0); relationship: PROBABLE

mild assessed 2026-08-18

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-02 (study day 3.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-02 (study day 3.0); relationship: PROBABLE

moderate assessed 2026-08-18

Moderate FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-14 (study day 46.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.